Results 1 to 10 of about 177,041 (162)

MicroRNAs in Cardiac Hypertrophy [PDF]

open access: yesInternational Journal of Molecular Sciences, 2019
Like other organs, the heart undergoes normal adaptive remodeling, such as cardiac hypertrophy, with age. This remodeling, however, is intensified under stress and pathological conditions. Cardiac remodeling could be beneficial for a short period of time, to maintain a normal cardiac output in times of need; however, chronic cardiac hypertrophy may ...
Gianfranco Pintus   +2 more
exaly   +7 more sources

CAMTA in Cardiac Hypertrophy [PDF]

open access: yesCell, 2006
In this issue of Cell, the Calmodulin binding transcription activator 2 (CAMTA2), is shown by Song et al. (2006) to be an indispensable transcription coactivator for cardiac hypertrophy. CAMTA2 is activated by the dissociation of class II histone deacetylase 5 and promotes transcription of genes involved in cardiac hypertrophy through its interaction ...
Schwartz, Robert J.   +1 more
openaire   +3 more sources

Cardiac hypertrophy at autopsy [PDF]

open access: yesVirchows Archiv, 2021
AbstractSince cardiac hypertrophy may be considered a cause of death at autopsy, its assessment requires a uniform approach. Common terminology and methodology to measure the heart weight, size, and thickness as well as a systematic use of cut off values for normality by age, gender, and body weight and height are needed.
Basso C.   +9 more
openaire   +8 more sources

Cardiac Nonmyocytes in the Hub of Cardiac Hypertrophy [PDF]

open access: yesCirculation Research, 2015
Cardiac hypertrophy is characterized by complex multicellular alterations, such as cardiomyocyte growth, angiogenesis, fibrosis, and inflammation. The heart consists of myocytes and nonmyocytes, such as fibroblasts, vascular cells, and blood cells, and these cells communicate with each other directly or indirectly via a variety of autocrine or ...
Takehiro, Kamo   +2 more
openaire   +2 more sources

Adiponectin and Cardiac Hypertrophy in Acromegaly [PDF]

open access: yesAdvances in Clinical and Experimental Medicine, 2016
Adiponectin is an adipocytes-derived hormone which has been shown to possess insulin-sensitizing, antiatherogenic, and anti-inflammatory properties. In acromegaly, the data on adiponectin is contradictory. The relationship between adiponectin levels and cardiac parameters has not been studied.The aim of this study was to find out how adiponectin levels
Sabriye, Gurbulak   +7 more
openaire   +6 more sources

Enigma in cardiac hypertrophy [PDF]

open access: yesCardiovascular Research, 2010
The Enigma subfamily belongs to the PDZ- (for PSD-95, DLG, ZO-1) and LIM- (for LIN-11, Isl-1, MEC-3) encoding protein family. This family is composed of at least four different members: Enigma (also called PD-LIM7; LMP-1), Enigma homologue (ENH), ZASP/Cypher/Oracle, and LMP-4.
openaire   +2 more sources

Glucose metabolism and cardiac hypertrophy [PDF]

open access: yesCardiovascular Research, 2011
The most notable change in the metabolic profile of hypertrophied hearts is an increased reliance on glucose with an overall reduced oxidative metabolism, i.e. a reappearance of the foetal metabolic pattern. In animal models, this change is attributed to the down-regulation of the transcriptional cascades promoting gene expression for fatty acid ...
Stephen C, Kolwicz, Rong, Tian
openaire   +2 more sources

Molecular biomarkers in cardiac hypertrophy [PDF]

open access: yesJournal of Cellular and Molecular Medicine, 2019
AbstractCardiac hypertrophy is characterized by an increase in myocyte size in the absence of cell division. This condition is thought to be an adaptive response to cardiac wall stress resulting from the enhanced cardiac afterload. The pathogenesis of heart dysfunction, which is one of the primary causes of morbidity and mortality in elderly people, is
Liu Zhu   +4 more
openaire   +2 more sources

Genetic determinants of cardiac hypertrophy [PDF]

open access: yesCurrent Opinion in Cardiology, 2008
Cardiac hypertrophy is a common phenotypic response of the heart to stimulants. It is associated with increased morbidity and mortality in various cardiovascular disorders. Genetic factors are important determinants of phenotypic expression of cardiac hypertrophy, whether in single-gene disorders or in complex traits. We focus on the molecular genetics
openaire   +2 more sources

Fueling Cardiac Hypertrophy [PDF]

open access: yesCirculation Research, 2020
Timothy R, Matsuura   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy